197 related articles for article (PubMed ID: 10848777)
1. Topoisomerase II inhibitor-related acute myeloid leukaemia.
Pui CH; Relling MV
Br J Haematol; 2000 Apr; 109(1):13-23. PubMed ID: 10848777
[No Abstract] [Full Text] [Related]
2. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
[TBL] [Abstract][Full Text] [Related]
3. Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents.
Nasr F; Macintyre E; Venuat AM; Bayle C; Carde P; Ribrag V
Leuk Lymphoma; 1997 Apr; 25(3-4):399-401. PubMed ID: 9168451
[TBL] [Abstract][Full Text] [Related]
4. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ
Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657
[TBL] [Abstract][Full Text] [Related]
5. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
Kobayashi Y; Hayashi Y; Ozawa K; Asano S
Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
[TBL] [Abstract][Full Text] [Related]
6. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies.
Zhang Y; Poetsch M; Weber-Matthiesen K; Rohde K; Winkemann M; Haferlach T; Gassmann W; Ludwig WD; Grote W; Löffler H; Schlegelberger B
Br J Haematol; 1996 Mar; 92(3):673-80. PubMed ID: 8616034
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of infant acute leukemia.
Hilden JM; Frestedt JL; Kersey JH
Leuk Lymphoma; 1997 Apr; 25(3-4):191-9. PubMed ID: 9168430
[TBL] [Abstract][Full Text] [Related]
8. Translocation (10;11)(p13;p15) in an infant acute myeloid leukemia with MLL gene rearrangement.
Marco F; Bureo E; Delgado MD; Richard C; Cuadrado MA; Pérez Retortillo JA; Recio M; Zubizarreta A
Cancer Genet Cytogenet; 1999 Oct; 114(1):68-70. PubMed ID: 10526538
[TBL] [Abstract][Full Text] [Related]
9. Secondary leukemias induced by topoisomerase-targeted drugs.
Felix CA
Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
[TBL] [Abstract][Full Text] [Related]
10. Disruption of a homolog of trithorax by 11q23 translocations: leukemogenic and transcriptional implications.
Waring PM; Cleary ML
Curr Top Microbiol Immunol; 1997; 220():1-23. PubMed ID: 9103672
[No Abstract] [Full Text] [Related]
11. Therapy-related T cell lymphoblastic lymphoma with t(11;19)(q23;p13) and MLL gene rearrangement.
Thandla S; Alashari M; Green DM; Aplan PD
Leukemia; 1999 Dec; 13(12):2116-8. PubMed ID: 10602439
[No Abstract] [Full Text] [Related]
12. Polymorphisms in the MLL breakpoint cluster region (BCR).
Echlin-Bell DR; Smith LL; Li L; Strissel PL; Strick R; Gupta V; Banerjee J; Larson R; Relling MV; Raimondi SC; Hayashi Y; Taki T; Zeleznik-Le N; Rowley JD
Hum Genet; 2003 Jul; 113(1):80-91. PubMed ID: 12665971
[TBL] [Abstract][Full Text] [Related]
13. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.
Megonigal MD; Cheung NK; Rappaport EF; Nowell PC; Wilson RB; Jones DH; Addya K; Leonard DG; Kushner BH; Williams TM; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2814-9. PubMed ID: 10706619
[TBL] [Abstract][Full Text] [Related]
14. Infant leukaemia biology, aetiology and treatment.
Greaves MF
Leukemia; 1996 Feb; 10(2):372-7. PubMed ID: 8637251
[No Abstract] [Full Text] [Related]
15. Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints.
Atlas M; Head D; Behm F; Schmidt E; Zeleznik-Le NH; Roe BA; Burian D; Domer PH
Leukemia; 1998 Dec; 12(12):1895-902. PubMed ID: 9844920
[TBL] [Abstract][Full Text] [Related]
16. Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.
Palle J; Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
Br J Haematol; 2005 Apr; 129(2):189-98. PubMed ID: 15813846
[TBL] [Abstract][Full Text] [Related]
17. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
18. [Therapy-related leukemia].
Yokozawa T; Naoe T
Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1007-12. PubMed ID: 12866446
[No Abstract] [Full Text] [Related]
19. Involvement of the MLL gene in T-lineage acute lymphoblastic leukemia.
Moorman AV; Richards S; Harrison CJ
Blood; 2002 Sep; 100(6):2273-4. PubMed ID: 12229886
[No Abstract] [Full Text] [Related]
20. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation.
Satake N; Ishida Y; Otoh Y; Hinohara S; Kobayashi H; Sakashita A; Maseki N; Kaneko Y
Genes Chromosomes Cancer; 1997 Sep; 20(1):60-3. PubMed ID: 9290955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
